Top-rated biotechs with negative enterprise values
Source: SeekingAlpha
2025-03-01 14:28:42 ET
More on iShares Biotechnology ETF, SPDR S&P Biotech ETF, etc.
- XBI: Diverse Holding Amid Strong Catalysts, Buy
- 2025 Analyst Outlook: Edmund Ingham On Biotech Big And Small, And A Key Milestone
- iShares Biotechnology ETF: Playing Defense
- Seeking Alpha’s Quant Rating on iShares Biotechnology ETF
- Dividend scorecard for iShares Biotechnology ETF
Read the full article on Seeking Alpha
For further details see:
Top-rated biotechs with negative enterprise values
Pyxis Oncology Inc.
NASDAQ: PYXS
PYXS Trading
1.28% G/L:
$1.525 Last:
141,174 Volume:
$1.54 Open:
PYXS Latest News
February 03, 2026 06:45:00 am
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
January 12, 2026 10:14:09 am
The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff
January 08, 2026 10:36:00 am
The $537B Precision Pivot: Why Molecular Monitoring is the New Oncology Standard
PYXS Stock Data
$126,496,274
71,256,534
0.76%
23
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
